Hypogonadism Clinical Trials

A listing of Hypogonadism medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35205

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Birmingham Alabama 35235

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Birmingham Alabama 35235

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Mobile Alabama 36608

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Arizona

Watching Over Mothers and Babies
Tucson Arizona

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

View More ▼

Tucson Arizona 85712

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

California

UCSF Center for Reproductive Health
San Francisco California

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

View More ▼

San Diego California 92120

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Colorado

University of Colorado School of Medicine
Aurora Colorado

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Delaware

Reproductive Associates of Delaware
Newark Delaware

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

District of Columbia

Columbia Fertility Associates
Washington District of Columbia

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Florida

Women's Medical Research Group
Clearwater Florida

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Center for Reproductive Medicine
Orlando Florida

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

View More ▼

Aventura Florida 33180

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Brandon Florida 33511

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Clearwater Florida 33756

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Jacksonville Florida 32223

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Jupiter Florida 33458

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Lakeland Florida 33805

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Oviedo Florida 32765

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

St. Petersburg Florida 33709

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Georgia

Georgia Reproductive Specialists
Atlanta Georgia

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Idaho

Boise Idaho 83704

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Illinois

Fertility Centers of Illinois
Chicago Illinois

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Kansas

Cypress Medical Research Center
Wichita Kansas

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Kentucky

Lexington Kentucky 40509

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Louisiana

Lake Charles Louisiana 70601

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Maine

Maine Medical Center
Portland Maine

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Massachusetts

Massachusetts General Hospital
Boston Massachusetts

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

View More ▼

Boston Massachusetts 02114

A clinical research study of Testosterone, Anastrazole and Goserelin acetate for the treatment of Healthy Volunteers

Chestnut Hill Massachusetts 02467

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Michigan

Wayne State University
Southfield Michigan

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Nebraska

Omaha Nebraska 68114

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Nevada

Las Vegas Nevada 89148

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

New Jersey

New York

Weill Cornell Medical Center
New York New York

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

View More ▼

Bronx New York 10468

A clinical research study of Testosterone Gel for the treatment of Pain or Hypogonadism

Buffalo New York 14215

A clinical trial seeking patients for a research study for the treatment of Type 2 Diabetic Male With Hypogonadotrophic Hypogonadism

Garden City New York 11530

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

New York New York 10028

A clinical trial seeking patients for a research study for the treatment of Hypogonadism

New York New York 10016

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

North Carolina

Carolinas Medical Center
Charlotte North Carolina

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Wake Forest University Health Sciences
Winston-Salem North Carolina

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Lyndhurst Clinical Research
Winston-Salem North Carolina

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

PMG Research of Winston-Salem
Winston-Salem North Carolina 27103

Low Testosterone associated with Hypogonadism

View More ▼

Fayetteville North Carolina 28314

Patients are needed to participate in a clinical research study evaluating SOV2012-F1 and AndroGel for the treatment of Hypogonadism, Male

Ohio

University of Cincinnati Physicians
Cincinnati Ohio

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism

Institute for Reproductive Health
Cincinnati Ohio

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism